1. Diagnostic utility of a novel magnifying endoscopic classification system for superficial Barrett’s esophagus-related neoplasms: a nationwide multicenter study
- Author
-
Ryu Ishihara, Hiroto Furuhashi, Akiko Takahashi, Tomoki Shimizu, Taku Yamagata, Satoru Hashimoto, Yasuhiro Takaki, Junko Fujiwara, Takashi Kanesaka, Yuji Amano, Manabu Takeuchi, Tsuneo Oyama, Yasuo Ohkura, Gen Watanabe, Kumiko Momma, Kenichi Goda, Masako Nishikawa, Takane Azumi, Yoichiro Ono, Junko Fujisaki, Kazuyoshi Yagi, and Dai Hirasawa
- Subjects
medicine.medical_specialty ,Esophageal Neoplasms ,Magnification ,03 medical and health sciences ,Special Article ,Magnification endoscopy ,Barrett Esophagus ,Narrow Band Imaging ,0302 clinical medicine ,medicine ,Barrett’s esophagus ,Humans ,Experience level ,Barrett's esophagus-related neoplasia ,Esophagus ,Reproducibility ,business.industry ,Significant difference ,Gastroenterology ,Reproducibility of Results ,medicine.disease ,medicine.anatomical_structure ,Multicenter study ,030220 oncology & carcinogenesis ,Barrett's esophagus ,030211 gastroenterology & hepatology ,Radiology ,Esophageal adenocarcinoma ,Esophagoscopy ,business ,Classification system - Abstract
Background Currently, no classification system using magnification endoscopy for the diagnosis of superficial Barrett’s esophagus (BE)-related neoplasia has been widely accepted. This nationwide multicenter study aimed to validate the diagnostic accuracy and reproducibility of the magnification endoscopy classification system, including the diagnostic flowchart developed by the Japan Esophageal Society—Barrett’s esophagus working group (JES-BE) for superficial Barrett’s esophagus-related neoplasms. Methods The JES-BE acquired high-definition magnification narrow-band imaging (HM-NBI) images of non-dysplastic and dysplastic BE from 10 domestic institutions. A total of 186 high-quality HM-NBI images were selected. Thirty images were used for the training phase and 156 for the validation (test) phase. We invited five non-experts and five expert reviewers. In the training phase, the reviewers discussed how to correctly predict the histology based on the JES-BE criteria. In the validation phase, they evaluated whether the criteria accurately predicted the histology results according to the diagnostic flowchart. The validation phase was performed immediately after the training phase and at 6 weeks thereafter. Results The sensitivity and specificity for all reviewers were 87% and 97%, respectively. Overall accuracy, positive predictive value, and negative predictive value were 91%, 98%, and 83%, respectively. The overall strength of inter-observer and intra-observer agreements for dysplastic histology prediction was κ = 0.77 and κ = 0.83, respectively. No significant difference in diagnostic accuracy and reproducibility between experts and non-experts was found. Conclusion The JES-BE classification system, including the diagnostic flowchart for predicting dysplastic BE, is acceptable and reliable, regardless of the clinician’s experience level.
- Published
- 2021